Liquidia Technologies has received a notice of allowance from the U.S. Patent and Trademark Office, indicating that…
David Melamed, PhD
David earned a PhD in Biological Sciences from Columbia University in New York, NY, where he studied how Drosophila ovarian adult stem cells respond to cell signaling pathway manipulations. This work helped to redefine the organizational principles underlying adult stem cell growth models. He is currently a Science Writer, as part of the BioNews Services writing team.
At Bionews we’re committed to providing the most accurate, relevant, and up-to-date reporting for our patient communities. Our goal is to ensure that everyone has access to disease-specific information that is both trustworthy and easy to understand. You can read more about our editorial policy here.
Articles by David Melamed, PhD
A team of researchers have used 3D cell culture technology to develop a model that replicates processes involved…
Pulmonary artery denervation was found to be safe and to improve the health of people with pulmonary arterial hypertension…
The European Medicines Agency (EMA) has granted priority medicines (PRIME) designation to investigational therapy sotatercept (ACE-011) for…